Arian Resources Corp.
ARCpoint Inc. provides franchise systems offering drug, alcohol, DNA, and clinical lab testing and screening services in the United States. It operates in two segments, ARCpoint Franchise and AFG Services. The company offers viral testing for viruses, such as Flu, Strep, and covid; regulatory compliance testing; ailments testing; preventive care services, including annual health, heart health, th… Read more
Arian Resources Corp. (ARC) - Net Assets
Latest net assets as of September 2025: CA$-7.54 Million CAD
Based on the latest financial reports, Arian Resources Corp. (ARC) has net assets worth CA$-7.54 Million CAD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CA$3.17 Million) and total liabilities (CA$10.71 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CA$-7.54 Million |
| % of Total Assets | -237.63% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Arian Resources Corp. - Net Assets Trend (2021–2024)
This chart illustrates how Arian Resources Corp.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Arian Resources Corp. (2021–2024)
The table below shows the annual net assets of Arian Resources Corp. from 2021 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CA$-6.56 Million | +36.84% |
| 2023-12-31 | CA$-10.39 Million | -648.02% |
| 2022-12-31 | CA$-1.39 Million | +50.59% |
| 2021-12-31 | CA$-2.81 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Arian Resources Corp.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1534625100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | CA$12.37 Million | % |
| Total Equity | CA$-6.47 Million | 100.00% |
Arian Resources Corp. Competitors by Market Cap
The table below lists competitors of Arian Resources Corp. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
MAKEMYTRIP (MY1.SG)
STU:MY1
|
$401.40K |
|
METCH INTL LTD. SD -25
F:VZ3P
|
$401.54K |
|
AbL Diagnostics SA
PA:ABLD
|
$401.58K |
|
NedSense Enterprises NV
AS:NEDSE
|
$401.94K |
|
ARES-P-B
PINK:ARES-P-B
|
$401.21K |
|
AXT (AHV.SG)
STU:AHV
|
$401.03K |
|
CDN NATURAL RES
MU:CRC
|
$400.56K |
|
TOKYO GAS - Dusseldorf Stock Exchang
DU:TOG
|
$400.48K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Arian Resources Corp.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -10,309,545 to -6,473,863, a change of 3,835,682.
- Net income of 1,357,910 contributed positively to equity growth.
- New share issuances of 1,761,634 increased equity.
- Other factors increased equity by 716,138.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CA$1.36 Million | +20.98% |
| Share Issuances | CA$1.76 Million | +27.21% |
| Other Changes | CA$716.14K | +11.06% |
| Total Change | CA$- | % |
Book Value vs Market Value Analysis
This analysis compares Arian Resources Corp.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | CA$-0.03 | CA$0.01 | x |
| 2022-12-31 | CA$-0.02 | CA$0.01 | x |
| 2023-12-31 | CA$-0.11 | CA$0.01 | x |
| 2024-12-31 | CA$-0.05 | CA$0.01 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Arian Resources Corp. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 24.66%
- • Asset Turnover: 1.69x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (0.00%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | 0.00% | 29.92% | 1.35x | 0.00x | CA$6.01 Million |
| 2022 | 0.00% | -73.87% | 0.72x | 0.00x | CA$-7.88 Million |
| 2023 | 0.00% | -129.90% | 0.99x | 0.00x | CA$-7.63 Million |
| 2024 | 0.00% | 24.66% | 1.69x | 0.00x | CA$2.01 Million |
Industry Comparison
This section compares Arian Resources Corp.'s net assets metrics with peer companies in the Diagnostics & Research industry.
No peer company data available for comparison.